AGENT FOR TREATMENT OF SKIN IMMUNE DISEASE Russian patent published in 2008 - IPC A61K31/573 A61K31/727 A61K31/593 A61P17/00 A61P5/44 

FIELD: medicine, dermatology, chemical-pharmaceutical industry, pharmacy.

SUBSTANCE: invention relates to drugs used in treatment of skin immune diseases displaying sensitivity to corticosteroid therapy. The claimed agent consists of glucocorticosteroids, heparin and vitamin D that provide the synergistic effect. Agent is used topically as ointment, cream, gel and solution wherein even ten-fold decrease of dose of glucocorticosteroids enhances effectiveness of treatment, reduces risk for development of complications caused by using steroids, and additional use of vitamin D improved state of protective properties of skin and inhibits development of osteoporosis. Hypocalcemia found before treatment was not observed after using dermatological agents comprising vitamin D. Invention provides enhancing effectiveness of treatment of patients with dermatitis associated with immunological responses of delayed type, decreasing inflammation symptoms and simultaneous elimination of complications associated with use of glucocorticosteroids.

EFFECT: valuable medicinal properties and enhanced effectiveness of agent.

2 cl, 3 tbl, 4 dwg, 7 ex